The activator/repressor protein DnrO of Streptomyces peucetius binds to DNA without changing its topology.

Int J Biol Macromol

Department of Genetic Engineering, School of Biotechnology, Madurai Kamaraj University, Madurai 625021, India.

Published: April 2010

Regulatory proteins that bind to upstream un-translated region often control transcription of prokaryotic genes. Many of these proteins bend or distort their DNA binding sites, and the induced DNA curvature facilitates protein-protein or protein-DNA contacts essential for transcriptional regulation. DnrO is an essential transcription regulator of Streptomyces peucetius that activates daunorubicin biosynthetic pathway. It binds to a specific sequence adjacent to dnrN promoter to activate transcription. The same binding event represses its own transcription. DNA binding domain of DnrO is within 60 aa from N-terminal end of the 340 aa protein. Helix-turn-helix motif in DnrO is similar to BirA repressor of E. coli. In this study, we show that this dual functional protein does not cause any localized bending of DNA as observed by circular permutation gel shift assay. This observation complements the functional role of DnrO as an activator/repressor, since the change in DNA topology might impede the activation or repression function if this protein. This is in variance with DNA bending property of BirA repressor and many other transcription factors. The possibility of G+C rich sequences in the target DNA not favoring distortion of major groove upon protein binding is discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijbiomac.2010.01.019DOI Listing

Publication Analysis

Top Keywords

streptomyces peucetius
8
dna
8
dna binding
8
bira repressor
8
dnro
5
transcription
5
activator/repressor protein
4
protein dnro
4
dnro streptomyces
4
peucetius binds
4

Similar Publications

sp. nov., a novel actinobacterium with antimicrobial activity isolated from the rhizospheric soil of D. Don.

Int J Syst Evol Microbiol

May 2024

Key Laboratory of Southwest China Wildlife Resources Conservation (Ministry of Education), College of Life Science, China West Normal University, Nanchong 637009, Sichuan Province, PR China.

A novel actinobacterium, designated strain CWNU-1, was isolated from the rhizospheric soil of D. Don and examined using a polyphasic taxonomic approach. The organism developed pale blue aerial mycelia that was simply branched and terminated in open or closed coils of three or more volutions on International Project 3 agar.

View Article and Find Full Text PDF

Enhancement of doxorubicin production in Streptomyces peucetius by genetic engineering and process optimization.

AMB Express

April 2024

National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, State Institute of Pharmaceutical Industry, 285 Gebaini Road, Pudong, Shanghai, 201203, P. R. China.

Doxorubicin is an important class of anthracycline antitumor antibiotics produced by Streptomyces peucetius. The doxorubicin fermentation yield of the wild-type strain was very low, so it could not be produced directly by fermentation at an industrial scale due to the high cost. In the present study, S.

View Article and Find Full Text PDF

Daunorubicin and doxorubicin, two anthracycline polyketides produced by , are potent anticancer agents that are widely used in chemotherapy, despite severe side effects. Recent advances have highlighted the potential of producing improved derivatives with reduced side effects by incorporating l-rhodosamine, the -dimethyl analogue of the native amino sugar moiety. In this study, we aimed to produce -dimethylated anthracyclines by engineering the doxorubicin biosynthetic pathway in the industrial strain G001.

View Article and Find Full Text PDF

A new peucemycin derivative and impacts of peuR and bldA on peucemycin biosynthesis in Streptomyces peucetius.

Appl Microbiol Biotechnol

December 2024

Department of Life Science and Biochemical Engineering, Sun Moon University, 70 Sun Moon-Ro 221, Tangjeong-Myeon, Asan-Si, 31460, Chungnam, Korea.

Streptomyces peucetius ATCC 27952 is known to produce a variety of secondary metabolites, including two important antitumor anthracyclines: daunorubicin and doxorubicin. Identification of peucemycin and 25-hydroxy peucemycin (peucemycin A), as well as their biosynthetic pathway, has expanded its biosynthetic potential. In this study, we isolated a new peucemycin derivative and identified it as 19-hydroxy peucemycin (peucemycin B).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!